Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access

Diagnosis and treatment of severe sepsis

Yann-Erick Claessens and Jean-François Dhainaut*

Critical Care 2007, 11(Suppl 5):S2 doi:10.1186/cc6153

Accesses  

  • Last 30 days: 296 accesses
  • Last 365 days: 4541 accesses
  • All time: 24159 accesses